Completion of the TRYPTIK®2 C-PLATE study

Spineart is delighted to announce that the TRYPTIK®2 C-Plate study has been recently completed with 42 patients enrolled!

These patients were treated with TRYPTIK®2 C-Plate Anterior Cervical Plate System between 2018 and 2020 in Spain, and retrospective/prospective data were collected to at least 1 year post surgery as per standard practice, to support the clinical safety, performance, and benefit of our device. 

We would like to thank Dr. Garcia from the Hospital Clínico Universitario de Valencia, as well as his team, for their involvement and dedication to this clinical study.

Dr. Garcia on the TRYPTIK®2 C-Plate: “TRYPTIK®2 C-Plate is easy to use and ensure a very good stability”.

Related

Related items
Date - Category Illustration Title Excerpt
  • BAGUERA® C
Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the United States to a motion-preserving solution for patients suffering from...
  • Corporate
26 September 2025 Plan-Les-Ouates & Zurich (CH) – Antwerp (BE) Spineart (www.spineart.com), a global medtech innovator in advanced spine surgery solutions, today announces a CHF 25 million capital increase backed...
  • Product
Spineart announces the full-market launch of its SCARLET® AC-Ti secured anterior cervical cage in the United States. Following 510(k) clearance in May 2024, SCARLET® AC-Ti has been extensively evaluated by...